M F Böttcher1, B Björkstén, S Gustafson, T Voor, M C Jenmalm. 1. Department of Molecular and Clinical Medicine, Division of Paediatrics and Clinical Research Centre, Faculty of Health Sciences, Linköping University, S-881-85 Linköping, Sweden. malfa@imk.liu.se
Abstract
BACKGROUND: Immune responses, including those to allergens, may be T helper (Th)2 skewed in newborns. In order to redress the fetal Th1/Th2 imbalance, Th1-stimulating factors, such as bacterial endotoxin, may be required. The increasing prevalence and severity of atopic diseases in industrialized countries, which are in marked contrast with the low prevalence of allergy among children in the formerly socialist countries of Europe, have been suggested to be caused by a reduced microbial stimulation. AIM: To relate the endotoxin levels in house dust from two countries with a low (Estonia) and a high (Sweden) prevalence of allergy to the development of atopic disease and sensitization in the children during the first 2 years of life. METHODS: The study included 108 children from Tartu, Estonia and 111 children from Linköping, Sweden. Skin prick tests were performed at 3, 6, 12 and 24 months of age, and questionnaires were distributed to the families. At 24 months, a paediatrician examined the children. Dust samples were collected from mattresses and carpets and the endotoxin concentration was determined by a chromogenic Limulus assay. RESULTS: The endotoxin levels were higher in Estonian than in Swedish house dust (median levels 29 (range 0.25-280) and 14 (range 0.25-99) EU/mg dust, respectively, P < 0.001). Furthermore, the levels were inversely related to the development of atopic disease and sensitization in the Swedish, but not in the Estonian, children. CONCLUSIONS: The low prevalence of atopic disease in Estonia may, at least in part, be related to the high endotoxin levels in this country. The findings support that high levels of endotoxin, or other bacterial products with Th1-stimulating properties, might protect children from developing atopic disease.
BACKGROUND: Immune responses, including those to allergens, may be T helper (Th)2 skewed in newborns. In order to redress the fetal Th1/Th2 imbalance, Th1-stimulating factors, such as bacterial endotoxin, may be required. The increasing prevalence and severity of atopic diseases in industrialized countries, which are in marked contrast with the low prevalence of allergy among children in the formerly socialist countries of Europe, have been suggested to be caused by a reduced microbial stimulation. AIM: To relate the endotoxin levels in house dust from two countries with a low (Estonia) and a high (Sweden) prevalence of allergy to the development of atopic disease and sensitization in the children during the first 2 years of life. METHODS: The study included 108 children from Tartu, Estonia and 111 children from Linköping, Sweden. Skin prick tests were performed at 3, 6, 12 and 24 months of age, and questionnaires were distributed to the families. At 24 months, a paediatrician examined the children. Dust samples were collected from mattresses and carpets and the endotoxin concentration was determined by a chromogenic Limulus assay. RESULTS: The endotoxin levels were higher in Estonian than in Swedish house dust (median levels 29 (range 0.25-280) and 14 (range 0.25-99) EU/mg dust, respectively, P < 0.001). Furthermore, the levels were inversely related to the development of atopic disease and sensitization in the Swedish, but not in the Estonian, children. CONCLUSIONS: The low prevalence of atopic disease in Estonia may, at least in part, be related to the high endotoxin levels in this country. The findings support that high levels of endotoxin, or other bacterial products with Th1-stimulating properties, might protect children from developing atopic disease.
Authors: Kinjal Maniar-Hew; Candice C Clay; Edward M Postlethwait; Michael J Evans; Justin H Fontaine; Lisa A Miller Journal: Am J Respir Cell Mol Biol Date: 2013-11 Impact factor: 6.914
Authors: Haejin Kim; Kevin Tse; Linda Levin; David Bernstein; Tiina Reponen; Grace LeMasters; Zana Lummus; Anthony A Horner Journal: J Allergy Clin Immunol Date: 2012-03-03 Impact factor: 10.793
Authors: D R Ownby; E L Peterson; G Wegienka; K J Woodcroft; C Nicholas; E Zoratti; C C Johnson Journal: Indoor Air Date: 2013-02-08 Impact factor: 5.770
Authors: Dennis R Ownby; Edward L Peterson; L Keoki Williams; Edward M Zoratti; Ganesa R Wegienka; Kimberley J Woodcroft; Christine L M Joseph; Christine C Johnson Journal: Pediatr Allergy Immunol Date: 2010-01-14 Impact factor: 6.377
Authors: Bianca Schaub; Abdelouahab Bellou; Fiona K Gibbons; German Velasco; Monica Campo; Hongzhen He; Yurong Liang; Matthew W Gillman; Diane Gold; Scott T Weiss; David L Perkins; Patricia W Finn Journal: J Interferon Cytokine Res Date: 2004-09 Impact factor: 2.607